- Seen in older adults (peak age 50–70 years, strong male predominance, with >90% occurring in cigarette smokers; second most common benign parotid neoplasm), presenting with a painless, slow-growing, soft or fluctuant mass classically in the inferior pole (tail) of the parotid gland.
- Caused by heterotopic salivary ductal epithelium trapped within intraparotid lymph nodes during late encapsulation of the parotid gland:
- 1.Histopathology & Multicentricity: Bilayered oncocytic (mitochondria-rich) papillary epithelium lining cystic spaces within dense reactive lymphoid stroma; bilateral or multifocal in 10–15% of patients (synchronous or metachronous) and arises almost exclusively in the parotid gland.
- 2.Negligible Malignant Risk: Unlike pleomorphic adenoma, malignant transformation is exceedingly rare (<1%).
Imaging Findings
- Ultrasound (First-Line Salivary Gland Modality):
- –Classic Appearance ('Swiss-Cheese' Pattern): Well-circumscribed, oval or lobulated hypoechoic mass in the inferior pole (tail) of the superficial parotid lobe containing multiple anechoic cystic cavities separated by echogenic septa and solid mural nodules.
- –Colour Doppler: Demonstrates brisk central and septal hypervascularity within the solid lymphoid/oncocytic septations.
- MRI Parotid & Neck (Bilateral Parotid Assessment):
- –T1WI (Intrinsic T1-Bright Cysts): Solid lymphoid stroma is low-to-intermediate signal, while internal cystic spaces classically demonstrate intrinsic T1 hyperintensity due to cholesterol crystals, proteinaceous fluid, or methemoglobin.
- –T2WI: Cellular solid components show intermediate-to-low T2 signal (markedly darker than the 'lightbulb bright' myxoid stroma of pleomorphic adenoma), interspersed with focal T2-hyperintense cysts.
- –T1 C+ & Dynamic Contrast-Enhanced (DCE) MRI: Rapid early arterial contrast enhancement followed by rapid washout (>30% washout ratio, Type B time-intensity curve); post-contrast subtraction confirms non-enhancement of the T1-bright cysts.
- –DWI / ADC: Solid components demonstrate marked diffusion restriction due to densely packed lymphoid follicles and oncocytic cells—a key differentiator from pleomorphic adenoma, though it overlaps with lymphoma.
- –**SWI / T2* GRE: May show focal intracystic blooming artifact from hemorrhagic breakdown products within cystic spaces, with absence of calcification**.
- –Contralateral Parotid Inspection: Mandatory evaluation of the contralateral parotid tail on every MRI/CT scan because 10–15% of cases are bilateral or synchronous.
- FDG PET-CT, Nuclear Scintigraphy & Plain Radiograph Findings:
- –FDG PET-CT (Classic 'Incidentaloma' Pitfall): Demonstrates intense focal FDG avidity due to high mitochondrial density within oncocytic cells, frequently mimicking a metastatic parotid lymph node on staging PET-CT.
- –Tc-99m Pertechnetate Scintigraphy: Avidly concentrates Tc-99m pertechnetate and retains tracer after lemon-juice sialogogue administration ('hot' parotid nodule).
- –Plain Radiograph (X-Ray): Normal soft-tissue contour without calcification.
Differential Diagnosis
| Differential Diagnosis | Key Distinguishing Features |
|---|---|
Pleomorphic Adenoma | More common in younger/middle-aged females; strictly unilateral and solitary; 'lightbulb bright' on T2WI, facilitated diffusion (no diffusion restriction on DWI), and progressive delayed enhancement (Type A curve). |
Intraparotid Lymphoma / Metastatic Lymph Node | Also shows marked diffusion restriction and FDG avidity, but typically lacks the intrinsic T1-bright proteinaceous cysts and rapid arterial washout characteristic of Warthin tumour; systemic lymphadenopathy or primary cutaneous/scalp malignancy often present. |
Benign Lymphoepithelial Lesions (HIV / Sjögren Syndrome) | Bilateral multiple lymphoepithelial parotid cysts and solid nodules accompanied by diffuse glandular enlargement, xerostomia, or known HIV infection. |
Low-Grade Mucoepidermoid Carcinoma | Cystic and solid parotid mass that may contain mucinous T1-bright fluid, but lacks multifocality/bilaterality and demonstrates ill-defined margins or progressive invasion. |
Important Points to Remember
- Management of PET-CT Incidentalomas (UK NICE / RCR Guidelines): An incidental FDG-avid parotid tail nodule in an older smoker is most commonly a benign Warthin tumour; confirm with Ultrasound and US-guided FNAC / core biopsy rather than assuming metastatic disease.
- Conservative Treatment & Smoking Cessation: Once histologically confirmed by US-guided biopsy, management is either partial superficial parotidectomy or active clinical/ultrasound surveillance in elderly or comorbid patients (given <1% malignant transformation risk), alongside smoking cessation.